StonvexLoading…
StonvexCore line items from GTN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $768.00M | $3.10B | $2.30B | $1.55B |
Operating Income | $81.00M | $392.00M | $276.00M | $174.00M |
Net Income | $-20.00M | $-85.00M | $-75.00M | $-56.00M |
EPS (Diluted) | $-0.34 | $-1.41 | $-1.19 | $-0.95 |
Total Assets | $10.32B | $10.44B | $10.32B | $10.35B |
Total Liabilities | $7.56B | $7.63B | $7.51B | $7.52B |
Cash & Equivalents | $259.00M | $368.00M | $182.00M | $199.00M |
Free Cash Flow OCF − CapEx | $-18.00M | $181.00M | $112.00M | $123.00M |
Shares Outstanding | 97.00M | 97.00M | 96.00M | 96.00M |